PlainRecalls
FDA Drug Moderate Class II Terminated

Estradiol Vaginal Inserts, USP 10 mcg, packaged in a) 8 inserts/carton (NDC 0093-3223-08) and b) 18 inserts/carton (NDC 0093-3223-97), Rx only, Teva Women's Health, Inc. Subsidiary of Teva Pharmaceuticals USA, North Wales, PA 19454.

Reported: March 28, 2018 Initiated: March 19, 2018 #D-0620-2018

Product Description

Estradiol Vaginal Inserts, USP 10 mcg, packaged in a) 8 inserts/carton (NDC 0093-3223-08) and b) 18 inserts/carton (NDC 0093-3223-97), Rx only, Teva Women's Health, Inc. Subsidiary of Teva Pharmaceuticals USA, North Wales, PA 19454.

Reason for Recall

Defective Container: This recall is being initiated due to product complaints regarding difficulty in dispensing the tablet from the applicator.

Details

Recalling Firm
Teva Pharmaceuticals USA
Units Affected
640,486 vaginal inserts
Distribution
Distributed within the United States and Puerto Rico.
Location
North Wales, PA

Frequently Asked Questions

What product was recalled?
Estradiol Vaginal Inserts, USP 10 mcg, packaged in a) 8 inserts/carton (NDC 0093-3223-08) and b) 18 inserts/carton (NDC 0093-3223-97), Rx only, Teva Women's Health, Inc. Subsidiary of Teva Pharmaceuticals USA, North Wales, PA 19454.. Recalled by Teva Pharmaceuticals USA. Units affected: 640,486 vaginal inserts.
Why was this product recalled?
Defective Container: This recall is being initiated due to product complaints regarding difficulty in dispensing the tablet from the applicator.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 28, 2018. Severity: Moderate. Recall number: D-0620-2018.